Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin
- PMID: 12480310
- DOI: 10.1016/s0168-3659(02)00270-5
Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-beta-cyclodextrin
Abstract
Albendazole (ABZ) is a benzimidazole derivative with a broad spectrum of activity against human and animal helminthe parasites. ABZ has a very poor aqueous solubility. This study shows that hydroxypropyl-beta-cyclodextrin (HP-beta-CD) is able to form inclusion complexes with ABZ and that is able to increase its aqueous solubility. A synergistic effect exists between HP-beta-CD and citric acid. The combination of HP-beta-CD (200 mM) and citric acid (50 mM) allows dissolution of more than 1.5 mg of ABZ per ml. The aim of this study is the in vivo evaluation in sheep of a solution of the inclusion complex of ABZ with HP-beta-CD in comparison with a suspension of the same drug. A significant (P<0.05) increase in the relative bioavailability is obtained with the solution containing the ABZ-HP-beta-CD complex as measured by ABZSO plasma levels. The area under the curve (AUC(0--> proportional, variant )) of the solution is 37% higher than that obtained with the suspension. Likewise the peak plasma concentration (C(max)) is twice that of the solution while the time to reach C(max) (T(max)) is reduced.
Similar articles
-
Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.Parasitol Res. 2018 Mar;117(3):705-712. doi: 10.1007/s00436-017-5740-3. Epub 2018 Jan 11. Parasitol Res. 2018. PMID: 29327323 Clinical Trial.
-
Enhanced Solubility of Albendazole in Cyclodextrin Inclusion Complex: A Molecular Modeling Approach and Physicochemical Evaluation.Curr Drug Deliv. 2022;19(1):86-92. doi: 10.2174/1567201818666210614104234. Curr Drug Deliv. 2022. PMID: 34126897
-
Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.Anticancer Res. 2012 Sep;32(9):3659-66. Anticancer Res. 2012. PMID: 22993303
-
Cyclodextrin derivatives in pharmaceutics.Crit Rev Ther Drug Carrier Syst. 1995;12(4):311-37. doi: 10.1615/critrevtherdrugcarriersyst.v12.i4.20. Crit Rev Ther Drug Carrier Syst. 1995. PMID: 9501966 Review.
-
HP-β-CD for the formulation of IgG and Ig-based biotherapeutics.Int J Pharm. 2021 May 15;601:120531. doi: 10.1016/j.ijpharm.2021.120531. Epub 2021 Mar 26. Int J Pharm. 2021. PMID: 33775727 Review.
Cited by
-
Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.BMC Vet Res. 2012 May 28;8:71. doi: 10.1186/1746-6148-8-71. BMC Vet Res. 2012. PMID: 22640491 Free PMC article. Clinical Trial.
-
Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers.Antimicrob Agents Chemother. 2004 Mar;48(3):1051-4. doi: 10.1128/AAC.48.3.1051-1054.2004. Antimicrob Agents Chemother. 2004. PMID: 14982808 Free PMC article. Clinical Trial.
-
Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis.PLoS Negl Trop Dis. 2011 Sep;5(9):e1308. doi: 10.1371/journal.pntd.0001308. Epub 2011 Sep 6. PLoS Negl Trop Dis. 2011. PMID: 21909447 Free PMC article.
-
Cyclodextrins in delivery systems: Applications.J Pharm Bioallied Sci. 2010 Apr;2(2):72-9. doi: 10.4103/0975-7406.67003. J Pharm Bioallied Sci. 2010. PMID: 21814436 Free PMC article.
-
Advancements in cyclodextrin-based controlled drug delivery: Insights into pharmacokinetic and pharmacodynamic profiles.Heliyon. 2024 Oct 30;10(21):e39917. doi: 10.1016/j.heliyon.2024.e39917. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39553547 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous